Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-21Clinical Trial Update: Robotic Telesurgery in Urology [NA]
A robotic telesurgery trial for prostate cancer has been withdrawn from ClinicalTrials.gov.
-
CLINICAL_TRIALS withdrawal · 2026-04-08Clinical Trial Update: Niraparib, Abiraterone Acetate and Prednisone for mHSPC With Deleterious Homologous Recombination Repair Alterations [Phase 2]
A Phase 2 trial evaluating the combination of niraparib, abiraterone acetate, and prednisone for metastatic hormone-sensitive prostate cance…
-
CLINICAL_TRIALS withdrawal · 2026-04-03Clinical Trial Update: A Trial of SHR3680 in Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy [Phase 3]
A Phase 3 trial of SHR3680 in high-risk localized or locally advanced prostate cancer patients eligible for radical prostatectomy has been t…
-
CLINICAL_TRIALS withdrawal · 2026-03-24Clinical Trial Update: Effect of Intrarectal Ice Application on Pain, Anxiety, Cortisol Levels, Development of Complications, and Hospital Readmission in Transrectal Ultrasound-Guided Prostate Biopsy [NA]
The clinical trial evaluating intrarectal ice to reduce pain, anxiety, cortisol, complications, and readmission during transrectal ultrasoun…
-
CLINICAL_TRIALS withdrawal · 2026-03-23Clinical Trial Update: SUPERvised Three-month Exercise Program in MEN With Prostate cAncer Receiving Androgen-deprivaTioN thERapy [NA]
The trial evaluating a supervised three-month exercise program for men with prostate cancer on androgen deprivation therapy has been withdra…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2026-03-03Clinical Trial Update: Biopsy Collection for Men Undergoing Brachytherapy for Prostate Cancer
The clinical trial update indicates that the study on biopsy collection for men undergoing brachytherapy for prostate cancer has been withdr…
-
CLINICAL_TRIALS withdrawal · 2026-02-24Clinical Trial Update: Patient Recall of Cancer Screening and Diagnosis [NA]
ClinicalTrials.gov shows that the study NCT05014295 sponsored by Case Comprehensive Cancer Center has been withdrawn; it involves breast can…
-
CLINICAL_TRIALS withdrawal · 2026-02-17Clinical Trial Update: Evaluation of a Postural Rehabilitation Program Based on Sensory-motor Control in Men With Urinary Incontinence After Prostatectomy [NA]
A clinical trial evaluating a postural rehabilitation program based on sensory-motor control for urinary incontinence after prostatectomy ha…
-
CLINICAL_TRIALS withdrawal · 2026-01-23Clinical Trial Update: Expanded Access to NanoPac
The expanded access program for NanoPac (paclitaxel nanoparticle formulation) has been discontinued and is no longer available.
-
CLINICAL_TRIALS withdrawal · 2025-12-29Clinical Trial Update: Study to Assess [177Lu]Lu-PSMA-R2 (AAA602) and [225Ac]Ac-PSMA-R2 (AAA802) in Participants With PSMA-positive HRLPC [Phase 1, Phase 2]
A Phase 1/2 trial evaluating two PSMA-targeted radioligands, [177Lu]Lu-PSMA-R2 and [225Ac]Ac-PSMA-R2, in PSMA-positive prostate cancer parti…
-
CLINICAL_TRIALS withdrawal · 2025-11-18Clinical Trial Update: Effect of Ruxolitinib on Tumor Infiltrating Myeloid Cells [NA]
A clinical trial evaluating the effect of ruxolitinib on tumor-infiltrating myeloid cells in prostate cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-10-22Clinical Trial Update: Randomized Phase II Study of ADT + Abiraterone vs ADT + Docetaxel + Abiraterone [Phase 2]
The randomized Phase II study comparing ADT plus Abiraterone versus ADT plus Docetaxel plus Abiraterone in prostate cancer has been withdraw…
-
CLINICAL_TRIALS withdrawal · 2025-10-21Clinical Trial Update: PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer [Phase 2]
A Phase 2 trial evaluating PSMA-targeted 18F-DCFPyL PET/MRI for detecting prostate cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-10-15Clinical Trial Update: A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence [NA]
The University of Rochester's study evaluating focal salvage high-dose-rate brachytherapy for prostate gland recurrence has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-09-30Clinical Trial Update: Abbreviated Biparametric MRI (RSI + T2WI) for Prostate Cancer Detection: Correlation With Histopathology [Phase 2]
Phase 2 clinical trial evaluating abbreviated biparametric MRI (RSI + T2WI) for prostate cancer detection has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-09-29Clinical Trial Update: Race Impact on Efficacy of Niraparib Plus Abiraterone Acetate and Prednisone in Patients With Homologous Repair Deficient Castration-resistant Prostate Cancer [Phase 2]
Phase 2 trial assessing race-related differences in the efficacy of niraparib plus abiraterone acetate and prednisone in homologous recombin…
-
CLINICAL_TRIALS withdrawal · 2025-09-23Clinical Trial Update: Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer [Phase 2]
A Phase 2 trial evaluating pembrolizumab with androgen deprivation therapy and radiotherapy for high-risk localized prostate cancer has been…
-
CLINICAL_TRIALS withdrawal · 2025-09-17Clinical Trial Update: Circulating And Intra-Tumoral Chemokines In Patients With Prostate Cancer
This clinical trial update reports that the study assessing circulating and intratumoral chemokines in patients with prostate cancer has bee…
-
CLINICAL_TRIALS withdrawal · 2025-08-28Clinical Trial Update: Determination of Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict GI Radiation Toxicity
A clinical trial evaluating the assay cut-off for the RadTox diagnostic test to predict GI radiation toxicity in prostate cancer patients ha…
-
CLINICAL_TRIALS withdrawal · 2025-07-04Clinical Trial Update: Trimodality Approach of Low Dose iOnizing Radiation With or Without Neoadjuvant Pembrolizumab and Prostatectomy for Men With Intermediate/High Risk Prostate Cancer (TALON) [Phase 2]
A Phase 2 trial evaluating a trimodality approach using low-dose ionizing radiation with or without neoadjuvant pembrolizumab followed by pr…
-
CLINICAL_TRIALS withdrawal · 2025-06-25Clinical Trial Update: Evaluation of a Multimodal Strategy for Early Diagnosis of Men at High Genetic Risk of Prostate Cancer [NA]
A clinical trial evaluating a multimodal strategy for early diagnosis in men at high genetic risk for prostate cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-04-29Clinical Trial Update: Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer [Phase 1]
A Phase 1 trial of stereotactic body radiation therapy with cemiplimab (REGN2810) and/or ipilimumab before surgery for progressive advanced …
-
CLINICAL_TRIALS withdrawal · 2025-04-27Clinical Trial Update: Efficacy, Safety, and Pharmacokinetics of FP-014, 22.5 mg in Patients With Advanced Prostate Cancer [Phase 3]
A Phase 3 trial of FP-014 for advanced prostate cancer has been withdrawn, with no efficacy, safety, or pharmacokinetic results reported.
-
CLINICAL_TRIALS withdrawal · 2025-04-27Clinical Trial Update: Efficacy, Safety, and Pharmacokinetics of FP-014, 11.25 mg in Patients With Advanced Prostate Cancer [Phase 3]
A Phase 3 trial evaluating FP-014 (11.25 mg) in advanced prostate cancer has been withdrawn, though the update discusses its efficacy, safet…
-
CLINICAL_TRIALS withdrawal · 2025-04-23Clinical Trial Update: Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating hyperpolarized Carbon-13 pyruvate magnetic resonance spectroscopic imaging to predict treatment response…